Neuroone Medical Technologies
NeuroOne Medical Technologies Corporation is dedicated to advancing neuroscience through developing high-definition, minimally invasive electrodes for diagnostic and therapeutic neurological applications. The company focuses on innovative, patented thin film electrode technology to improve the diagnosis and treatment of neurological disorders, including epilepsy, with FDA-cleared products and exclusive partnerships with industry leaders. The company also specializes in brain monitoring solutions, including the FDA-cleared OneRF™ Radiofrequency Ablation System, which offers minimally invasive, bedside monitoring, mapping, and ablation for epilepsy patients, aiming to improve patient care and treatment outcomes.
Industries
Nr. of Employees
small (1-50)
Neuroone Medical Technologies
Patents
Minimally invasive electrode and delivery device and related systems and methods
US-11883649-B2
View Details
Minimally invasive electrode and delivery device and related systems and methods
US-11883649-B2
View DetailsProducts
OneRF™ Ablation System
A radiofrequency ablation system providing bedside monitoring, mapping, and ablation for epilepsy patients, FDA-cleared as the first and only sEEG-RF system.
Evo® Cortical Electrodes
High-resolution, flexible thin film electrodes used in electrocorticography (ECoG) or intracranial EEG surgeries for less than 30 days, designed to reduce immunological response and improve surgical outcomes.
Evo® sEEG Electrodes
Advanced diagnostic electrodes for seizure detection, designed for temporary use (less than 30 days) with high placement accuracy and signal quality, supporting better diagnosis and treatment planning.
OneRF™ Ablation System
A radiofrequency ablation system providing bedside monitoring, mapping, and ablation for epilepsy patients, FDA-cleared as the first and only sEEG-RF system.
Evo® Cortical Electrodes
High-resolution, flexible thin film electrodes used in electrocorticography (ECoG) or intracranial EEG surgeries for less than 30 days, designed to reduce immunological response and improve surgical outcomes.
Evo® sEEG Electrodes
Advanced diagnostic electrodes for seizure detection, designed for temporary use (less than 30 days) with high placement accuracy and signal quality, supporting better diagnosis and treatment planning.
News & Updates
North American Neuromodulation Society (NANS)
Presentation on percutaneous implantation and stimulation versatility of thin-film paddles in cadaveric and in vivo sheep studies.
Materials Research Society (MRS), Boston
Presentation on advancing thin film implants for spinal cord stimulation and innovations in electrode design.
American Epilepsy Society (AES), Los Angeles
Multiple presentations on sEEG-based drug delivery systems, FDA-cleared radiofrequency ablation systems, and clinical experiences.
A scientific article discussing the challenges and opportunities in cortical recordings for deep brain stimulation.
A study evaluating the implantation accuracy of NeuroOne's EVO® sEEG electrodes.
The Evo® Cortical Electrode is FDA 510(k) cleared for use in brain monitoring, recording, and stimulation.
North American Neuromodulation Society (NANS)
Presentation on percutaneous implantation and stimulation versatility of thin-film paddles in cadaveric and in vivo sheep studies.
Materials Research Society (MRS), Boston
Presentation on advancing thin film implants for spinal cord stimulation and innovations in electrode design.
American Epilepsy Society (AES), Los Angeles
Multiple presentations on sEEG-based drug delivery systems, FDA-cleared radiofrequency ablation systems, and clinical experiences.
A scientific article discussing the challenges and opportunities in cortical recordings for deep brain stimulation.
A study evaluating the implantation accuracy of NeuroOne's EVO® sEEG electrodes.
The Evo® Cortical Electrode is FDA 510(k) cleared for use in brain monitoring, recording, and stimulation.